Dublin, March 10, 2017 -- Research and Markets has announced the addition of the "Global Markets for Generic Drugs" report to their offering.
This report discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analyzed by the most important national markets. The nature and structure of the generics industry is discussed, with profiles of the leading 20+ generics companies and an update on M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.
Report Includes
- An overview of the global markets for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Examination of strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by originator companies to forestall generic competition
- Discussion of important trends by product categories and major country markets, acknowledging that Brazil, China, India, Mexico, and Russia are among the rising markets for generic activity
- Profiles of major players and leading generics companies
- A look at recent merger and acquisition activity
Key Topics Covered:
1: Introduction
- Study Goals And Objectives
- Reasons For Doing The Study
- Scope Of Report
- Market Analyses And Forecasts
- Methodology
- Intended Audience
- Information Sources
2: Summary
- Market Size And Evolution
Overview
- Recent History Of The Generics Sector
4: The New Generics Era
- The Patent Cliff
- Types Of Generics
5: Major Generic Issues
- Regulatory Environment
- Patents And IP
6: The Generics Market
- Global Pharmaceutical And Generics Market
- Market Opportunities By Product Class
7: Generics Markets And Forecasts By Country
- Americas
- Asia
- Europe
8: The Global Generics Industry
- Trends
- Structure Of The Generics Industry
- Recent M&A Activity
- Brand Company Involvement
- Profiles Of The Leading Generics Companies
- Other International Generics Companies
For more information about this report visit http://www.researchandmarkets.com/research/k6whpb/global_markets
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Generic Drugs


Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



